SlateRx Company Profile

Background

Overview

SlateRx is a healthcare company specializing in pharmacy benefit management (PBM) solutions. Founded in 2023, the company is headquartered in Boca Raton, Florida. SlateRx offers a transparent and cost-effective pharmacy benefit experience, aiming to optimize medication access, improve health outcomes, and control costs for employers, plan sponsors, and brokers.

Mission and Vision

• Mission: To optimize medication access, provide better outcomes, and control costs for those who receive and pay for healthcare services.

• Vision: To improve a disjointed pharmacy model and make benefits simpler, more affordable, and increasingly efficient for plan sponsors and members.

Industry Significance

SlateRx operates within the healthcare sector, focusing on pharmacy benefit management. The company addresses the challenges associated with traditional PBM models by offering innovative solutions that prioritize transparency, collaboration, and cost control. This approach positions SlateRx as a significant player in the evolving landscape of pharmacy benefits.

Key Strategic Focus

Core Objectives

• Transparency: Providing clear, honest, and easily understandable information to empower informed decision-making.

• Collaboration: Fostering strong relationships and teamwork to create a seamless, efficient, and member-centric approach to pharmacy benefits.

• Innovation: Exploring new and groundbreaking solutions to address the evolving needs of pharmacy management.

• Accountability: Upholding the highest standards of ethics and integrity, ensuring the best outcomes for clients and members.

Areas of Specialization

SlateRx specializes in delivering a new pharmacy benefit experience that combines the financial value of a large PBM with the concierge service of a pharmacy benefit administrator (PBA). This model offers plan sponsors control, flexibility, substantial savings, and protections not found in traditional PBM contracts.

Key Technologies Utilized

While specific technologies are not detailed in the available sources, SlateRx emphasizes the use of innovative solutions to optimize medication access and control costs. The company's commitment to transparency and collaboration suggests the integration of advanced data analytics and communication platforms to enhance service delivery.

Primary Markets Targeted

SlateRx primarily targets employers, plan sponsors, and brokers seeking more control and transparency in managing pharmacy benefits. The company's solutions are designed to address the needs of these groups by offering flexible programs, data access, and financial savings through expert support and custom innovations.

Financials and Funding

Funding History

Specific details regarding SlateRx's funding history, total funds raised, and recent funding rounds are not publicly disclosed in the available sources. The company is privately held with an estimated headcount of 11-50 employees.

Notable Investors

Information about notable investors in SlateRx is not available in the provided sources.

Utilization of Capital

While the exact utilization of capital is not specified, SlateRx's focus on innovation, transparency, and collaboration suggests that funds are likely allocated towards developing and enhancing their pharmacy benefit management solutions, expanding market reach, and strengthening client relationships.

Pipeline Development

As a relatively new entrant in the pharmacy benefit management sector, SlateRx's pipeline development is centered around refining and expanding its PBM solutions. The company's emphasis on transparency, collaboration, and innovation indicates ongoing efforts to enhance service offerings and address the evolving needs of employers, plan sponsors, and brokers. Specific details about pipeline candidates, stages of development, target conditions, and timelines are not publicly disclosed.

Technological Platform and Innovation

Proprietary Technologies

While specific proprietary technologies are not detailed in the available sources, SlateRx's commitment to innovation suggests the development of unique platforms and tools to deliver its pharmacy benefit solutions.

Significant Scientific Methods

The company employs a custom clinical model that includes an independent Pharmacy and Therapeutics (P&T) committee and true utilization management. This approach ensures that plan sponsors' interests are aligned and protected, and that patients receive the safest, most efficacious care while minimizing waste.

AI-Driven Capabilities

Specific details regarding AI-driven capabilities are not provided in the available sources.

Leadership Team

Executive Profiles

• Joey Dizenhouse: President and Chief Executive Officer. Joey leads SlateRx with a focus on redefining pharmacy benefits through innovative solutions.

• Darren Eckberg: Chief Growth Officer. Darren brings over 25 years of experience in driving revenue growth and market expansion across the PBM, digital health, and post-acute care sectors. He joined SlateRx as Chief Growth Officer in March 2026.

• Ben Glatter: Chief Financial Officer. Ben oversees the financial operations of SlateRx, ensuring fiscal responsibility and strategic financial planning.

• Jennilyn Nevins: General Counsel. Jennilyn provides legal guidance and ensures compliance with regulatory standards.

• Amanda Peterson: Chief Administrative Officer. Amanda manages administrative functions, supporting the company's operational efficiency.